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Abstract
Epidemiological and evolutionary dynamics of influenza B Victoria and Yamagata lineages
remained poorly understood in the tropical Southeast Asia region, despite causing seasonal
outbreaks worldwide. From 2012–2014, nasopharyngeal swab samples collected from out-
patients experiencing acute upper respiratory tract infection symptoms in Kuala Lumpur,
Malaysia, were screened for influenza viruses using a multiplex RT-PCR assay. Among
2,010/3,935 (51.1%) patients infected with at least one respiratory virus, 287 (14.3%) and
183 (9.1%) samples were tested positive for influenza A and B viruses, respectively. Influ-
enza-positive cases correlate significantly with meteorological factors—total amount of rain-
fall, relative humidity, number of rain days, ground temperature and particulate matter
(PM10). Phylogenetic reconstruction of haemagglutinin (HA) gene from 168 influenza B
viruses grouped them into Yamagata Clade 3 (65, 38.7%), Yamagata Clade 2 (48, 28.6%)
and Victoria Clade 1 (55, 32.7%). With neuraminidase (NA) phylogeny, 30 intra-clade (29
within Yamagata Clade 3, 1 within Victoria Clade 1) and 1 inter-clade (Yamagata Clade 2-
HA/Yamagata Clade 3-NA) reassortants were identified. Study of virus temporal dynamics
revealed a lineage shift from Victoria to Yamagata (2012–2013), and a clade shift from
Yamagata Clade 2 to Clade 3 (2013–2014). Yamagata Clade 3 predominating in 2014 con-
sisted of intra-clade reassortants that were closely related to a recent WHO vaccine candi-
date strain (B/Phuket/3073/2013), with the reassortment event occurred approximately 2
years ago based on Bayesian molecular clock estimation. Malaysian Victoria Clade 1
viruses carried H274Y substitution in the active site of neuraminidase, which confers resis-
tance to oseltamivir. Statistical analyses on clinical and demographic data showed Yama-
gata-infected patients were older and more likely to experience headache while Victoria-
infected patients were more likely to experience nasal congestion and sore throat. This
study describes the evolution of influenza B viruses in Malaysia and highlights the impor-
tance of continuous surveillance for better vaccination policy in this region.
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Introduction
Influenza A and B viruses are important pathogens to humans, contributing to a large propor-
tion of morbidity and mortality in respiratory infections worldwide [1]. Both viruses have a
segmented negative-stranded genome with an enveloped structure [2]. Due to the limited host
range (with no natural animal hosts other than humans and seals) of influenza B viruses as
compared to influenza A viruses [3], antigenic shift does not occur in influenza B viruses, and
hence they have little pandemic potential [4]. However, influenza B viruses evolve through
antigenic drift, enabling them to escape host immunity and continue to adapt to new environ-
ments [5], causing significant disease burden to the global population [6]. Two major geneti-
cally and antigenically distinct influenza B lineages, B/Victoria/2/87-like (Victoria lineage) and
B/Yamagata/16/88-like (Yamagata lineage) have been detected since 1983 [7, 8]. However, in
recent decades, the changing demographics and rapid movement of human populations
between countries [9] have resulted in the co-circulation and recurring outbreaks of two influ-
enza B lineages in many regions of the world [6, 10–19].
Studies have shown that the tropical East and Southeast Asia region played a role in reseed-
ing new genetic variants of influenza A (H3N2) viruses in the temperate region, causing an
annual H3N2 epidemic worldwide [20, 21]. In contrast, recent phylogeographic analyses from
2000 to 2012 revealed that influenza B Victoria and Yamagata lineage viruses within East and
Southeast Asia region commonly circulate exclusively within this region for several years with
limited spreading to other regions [22]. Whether this region continues to play a role in global
influenza B epidemics still requires further investigation as recent dominant strains isolated in
several countries in both Northern and Southern hemispheres during the 2014/2015 season
were closely related to strains with a Southeast Asia origin [23, 24].
A recent report on the evolution and epidemiology of influenza B virus in Malaysia form
1995–2008, which generally involved the children population, described the incidence and evo-
lutionary changes of predominant circulating Victoria and Yamagata lineages over the years
[25]. In view of this, we had conducted an influenza surveillance on more adult and elderly
patients with respiratory infections and investigated the epidemiological and evolutionary
dynamics of influenza B lineages circulating in Malaysia between 2012 and 2014 using phyloge-
netic methods. Clinical presentation and demographic profile of patients infected by both line-
ages were compared. Although studies in temperate regions have highlighted the role of
humidity and temperature in shaping influenza seasonality [26–28], such studies were lacking
in the tropical Southeast Asia region. Hence, we also aimed to identify possible meteorological
predictors that drive the seasonal periodicity of influenza viruses by associating climatic vari-
ables to influenza activities.
Materials and Methods
Ethical Statement
This study was approved by the University of Malaya Medical Centre (UMMC) Medical Ethics
Committee (MEC890.1). Standard, multilingual consent forms validated by the Medical Com-
mittee were used. Written consent was obtained from all study participants.
Clinical Specimen Collections
A total of 3,935 nasopharyngeal swab samples were collected from outpatients experiencing
symptoms of acute upper respiratory tract infection at the Primary Care Clinic of UMMC in
Kuala Lumpur, Malaysia between February 2012 and May 2014. The presence of symptoms
associated with acute respiratory tract infection (sneezing, nasal discharge, nasal obstruction,
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headache, sore throat, hoarseness of voice, muscle ache and cough) was self-recorded by the
patient on a questionnaire, which was designed based on previously reported criteria [29]. The
nasopharyngeal samples were then transported in universal transport medium to the labora-
tory and stored at -80°C before further processing.
Rapid Detection, Amplification and Sequencing of Influenza B Viruses
Total nucleic acids from nasopharyngeal samples were extracted using the NucliSENS easy-
MAG automated nucleic acid extraction system (BioMérieux, France) [30, 31]. Influenza B
viruses and other respiratory viruses (including influenza A viruses) were then detected using
the xTAG Respiratory Virus Panel (RVP) FASTmultiplex RT-PCR assay (Luminex Molecular
Diagnostics, USA) [32, 33]. Both extraction and detection procedures were performed based
on manufacturer’s protocol.
A two-step reverse transcription PCR (RT-PCR) approach was adopted following protocols
recommended by the World Health Organization (WHO) on influenza B-positive samples
[34]. The HA and NA genes were amplified as overlapping halves using WHO-recommended
gene specific primers (primer sequences and cycling conditions are listed in S1 Table). PCR
products were purified and sequencing was performed in an ABI PRISM 3730XL Genetic Ana-
lyzer using the BigDye Terminator v3.1 cycle sequencing kit chemistry (Applied Biosystems,
USA). The HA and NA sequence reads were assembled into a contig and aligned with the
WHO vaccine and reference sequences.
Phylodynamic Analysis of the HA and NA Genes
Evolutionary analyses of HA and NA gene sequences were carried out on all Malaysian influ-
enza B viruses and other related virus strains worldwide. Our sequence data set included those
from the Global Initiative on Sharing all Influenza Data (GISAID) [35] and GenBank within
the study period. WHO recommended vaccine and reference strains were also included [23,
24]. All gene sequences were edited and aligned in the BioEdit 7.2 [36]. Phylogenetic trees of
the HA and NA genes were reconstructed using maximum likelihood (ML) method heuristi-
cally inferred using subtree pruning and regrafting and nearest neighbor interchange algo-
rithms with general time-reversible (GTR) nucleotide substitution model, a proportion of
invariant sites (+I) and four categories of gamma rate heterogeneity (+Γ4), implemented in
PAUP version 4.0 [37]. Robustness of the branching orders was evaluated by bootstrap analysis
of 1,000 replicates.
Molecular clock dating analysis using the Bayesian Markov chain Monte Carlo (MCMC)
method implemented in BEAST 1.7 [38] was used to estimate the timescale for the emergence
of the B/Phuket/3073/2013-like viruses detected in the region, as previously described [14, 39–
41]. The uncorrelated lognormal relaxed clock model with GTR+I+Γ4 nucleotide substitution
model and Bayesian skyline plot (BSP) model was employed to estimate the posterior distribu-
tion of phylogenies, nucleotide substitution rates, and the time of most recent common ances-
tor (tMRCA) of B/Phuket/3073/2013-like viruses. Three independent MCMC runs of 50
million steps sampled for every 50,000 states were performed on HA and NA genes separately.
The MCMC sampling was assessed for convergence (effective sampling size> 200) after 10%
burn-in using Tracer 1.4 (http://tree.bio.ed.ac.uk). Bayesian maximum clade credibility (MCC)
trees were annotated using TreeAnnotator in BEAST package and visualized in FigTree (http://
tree.bio.ed.ac.uk/software/figtree/) to determine the posterior probability of B/Phuket/3073/
2013-like clade.
Influenza B Viruses in Malaysia
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Statistical Analysis on Meteorological, Demographical and Clinical Data
To understand the seasonality of influenza viruses in Malaysia, meteorological data were
obtained from the Malaysian Meteorological Department (Kuala Lumpur) (03°06'N, 101°39'E).
Meteorological factors including daily rainfall amount, number of rainy days, relative humid-
ity, ground temperature and particulate matter with size less than 10 micrometers in diameter
(PM10) were collected between February 2012 and May 2014. The associations between these
data and influenza-positive cases were determined through linear correlation (bivariate and
partial) and regression analysis using the Statistical Package for Social Sciences version 22.0
(SPSS Inc., Chicago, USA). Demographic and clinical features between patients infected with
influenza B Victoria lineage and Yamagata lineage were also compared using independent sam-
ples t-test. Association between symptoms and lineages was accessed using Pearson’s chi-
square or Fischer’s exact test and binary logistic regression [42].
Nucleotide Sequence Accession Numbers
HA and NA nucleotide sequences of the Malaysian influenza B viruses generated in this study
are available in GenBank under accession numbers KR073326-KR073659.
Results
Seasonality of Influenza Viruses in Malaysia
During the study period from February 2012 to May 2014, a total of 287 (14.3%) and 183
(9.1%) samples tested positive for influenza A and B viruses, respectively among 2,010/3,935
(51.1%) patients infected with at least one respiratory virus. We found that the seasonality of
influenza viruses showed similar patterns with meteorological factors such as the total amount
of rainfall, relative humidity and number of rain days, such that peaks were observed between
October to May, and hit their lowest marks around June to September in 2012 and 2013 (Fig
1A and 1C). However, both particulate matter (PM10) and ground temperature showed oppo-
site trends as influenza activity was reduced during an increase in particular matter and ground
temperature (Fig 1B and 1C).
The bivariate correlation between three meteorological factors (total amount of rainfall, rela-
tive humidity and number of rain days) and number of influenza cases were significantly posi-
tive (p< 0.05), while both particulate matter and ground temperature showed significant
negative correlation (p< 0.05) with number of influenza cases (Table 1). Though, partial corre-
lation showed that only ground temperature was significantly associated with the number of
influenza cases (p< 0.05). A multiple linear regression analysis showed that the linear combina-
tion of all five meteorological factors (non-ordered predictors) was significantly related to the
number of influenza cases (outcome) (R2 = 0.458, adjusted R2 = 0.329, F (5, 21) = 3.549,
p< 0.05). Based on both linear correlational and regression analyses, ground temperature is per-
haps the main predictor (standard regression coefficient, beta = -0.545, t (26) = -2.308, p< 0.05)
which accounts for 40.5% (r: -0.636, R2 = 0.405) of the variance of the number of influenza cases,
while the other variables contributed only an additional 5.3% (45.8%- 40.5% = 5.3%). However,
such judgments about the relative importance of these predictors are challenging because they
are also correlated among themselves (range of r: 0.407–0.931, p< 0.05, data not shown).
Notable characteristic waves of influenza viruses were also observed (Fig 1C): First, influ-
enza A cases consistently peaked ahead of influenza B and fell between September and January,
whereas influenza B cases peaked later between February and April when influenza A cases
decreased. Second, the overall prevalence of influenza B infection was consistently lower than
that of influenza A virus.
Influenza B Viruses in Malaysia
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Phylogenetic Classification of Influenza B Viruses
A total of 168 full-length HA and 166 full-length NA gene sequences were obtained from 170
patients in the present study (S2 Table). Additional 23 Malaysian influenza B viruses with full-
length HA and NA gene sequences and collection dates from January 2012 to June 2014 were
also retrieved from GISAID and GenBank databases. These published sequences were originated
from the National Influenza Centre at the Institute of Medical Research (IMR) Malaysia. Hence,
a total of 193 Malaysian influenza B viruses were included for phylogenetic classification.
Phylogenetic analysis of the HA sequences (1,758bp) shows that 67.3% (113/168) of Malay-
sian influenza B viruses from this study belonged to Yamagata lineage, while 32.7% (55/168)
viruses belonged to Victoria lineage (Fig 2, S1 Fig). In contrast, evaluation of the NA sequences
(1,401bp) shows that all 166 viruses from this study belonged to the Yamagata lineage (Fig 3,
Fig 1. Seasonality of influenza infections andmeteorological factors in Malaysia between 2012 and
2014. (A) Total Rainfall Amount (mm), Mean Relative Humidity (%) and Number of Rain Days. (B) Mean
Particulate Matter—PM10 (μg/m3) and Ground Temperature (°C). (C) Monthly distribution of influenza A and
B infections in Kuala Lumpur, Malaysia.
doi:10.1371/journal.pone.0136254.g001
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S2 Fig). Both phylogenies indicate that all Malaysian Victoria viruses detected had Victoria-
lineage HA and Yamagata-lineage NA. This inter-lineage reassortment has long been seen in
B/Brisbane/60/2008-like viruses in previous studies [13, 18, 43, 44], which were derived from
B/Brisbane/32/2002-like viruses. They have a HA gene segment that evolved from B/Shang-
dong/7/97-like viruses of Victoria lineage and NA gene segment that evolved from B/Sichuan/
379/99-like viruses of Yamagata lineage [39].
Our 2012–2014 Malaysian influenza B viruses were grouped into 3 major clades in the HA
and NA phylogenies: Yamagata Clade 3 (Yam-3), Yamagata Clade 2 (Yam-2) and Victoria
Clade 1 (Vic-1A and Vic-1B), based on the recent WHO genetic groupings [23, 24] (Figs 2 and
3, S1 and S2 Figs). In Yam-3, two well-supported (>70% bootstrap) subclades, represented by
B/Wisconsin/01/2010-like (Wisconsin/01-like) and B/Stockholm/12/2011-like (Stockholm/
12-like) were identified. From there we detected a major group of intra-clade reassortants shar-
ing HA and NA genes fromWisconsin/01-like and Stockholm/12-like subclades, respectively.
The earliest strain (B/Malaysia/U2462/2013) of such HA-NA reassortant form was sampled on
31st May 2013. By including other Malaysian influenza B viruses isolated from IMR, the num-
ber of similar intra-clade reassortants was found to increase to 32 in Malaysia by June 2014,
and they formed a marginally-supported new monophyletic subclade (>80% bootstrap value
for NA phylogeny but<60% for HA phylogeny) according to WHO recommendations [45].
We further assessed the phylogenetic positions of 2,005 global full-length HA and NA
sequences retrieved from GISAID and GenBank databases with a collection year of 2012–2015,
and we identified 446 sequences from other countries that fell into this new subclade which
had HA and NA gene that derived fromWisconsin/01-like subclade and Stockholm/12-like
subclade respectively (S3 and S4 Figs). Interestingly, a recent WHO recommended candidate
vaccine strain for the Northern and Southern Hemisphere of the 2015–2016 influenza season
—B/Phuket/3073/2013 strain from Thailand, fell into this new subclade as well [23, 24]. Thus,
we conveniently denote this new subclade as Phuket/3073-like subclade. Though it is notewor-
thy that B/Malaysia/U2462/2013 was by far the earliest strain detected in this subclade (on 31st
May 2013)- 5 months before B/Phuket/3073/2013 was sampled (on 21st November 2013). The
Table 1. Linear correlations and regression betweenmeteorological factors and number of influenza positive cases (March 2012 –May 2014).
Bivariate
Correlations
(Correlation
between each
predictors and
the no. of
positive cases)
Partial
Correlations
(Correlation
between each
predictor and
the no. of
positive cases
controlling for
all other
predictors)
Standardized regression coefﬁcients t
Meteorological Factors (Predictors) Mean (± S.D.) r p r p Beta t
Total Rainfall Amount (mm) 287.867 (± 168.141) 0.545 0.003* 0.176 0.423 0.265 0.817
Relative Humidity (%) 76.259 (±5.015) 0.518 0.006* -0.143 0.514 -0.391 -0.664
No. of Rain Days 16.590 (±5.995) 0.520 0.005* 0.154 0.482 0.351 0.716
Particulate Matter (μg/m3) 38.551 (±12.352) -0.407 0.035* 0.029 0.896 0.034 0.132
Ground Temperature (°C) 28.200 (±0.747) -0.636 <0.001* -0.450 0.031* -0.545 -2.308
S.D.: standard deviation; r: Pearson correlation coefﬁcient (high correlation: 0.5 to 1.0 or -0.5 to -1.0; moderate correlation: 0.3 to 0.5 or -0.3 to -0.5); p:
level of signiﬁcance (2-tailed);
* correlation is signiﬁcant at the 0.05 level.
doi:10.1371/journal.pone.0136254.t001
Influenza B Viruses in Malaysia
PLOS ONE | DOI:10.1371/journal.pone.0136254 August 27, 2015 6 / 21
earliest non-Malaysian strain (B/Dominican Republic/7672/2013) was sampled in the Domini-
can Republic on 12th July 2013 (S3–S6 Figs).
Phylogenetic classification of Malaysian influenza B viruses into lineages, clades and sub-
clades allowed better understanding of their prevalence and temporal distribution in Malaysia
with greater details (Fig 4). Based on HA phylogeny, the overall prevalence of Yam-3, Yam-2
Fig 2. Phylogenetic analysis of the HA gene of influenza B viruses in Malaysia from 2012 to 2014.HA sequences of Malaysian influenza B viruses
were compared with WHO recommended candidate vaccine and reference strains. The phylogeny was reconstructed using maximum likelihood (ML)
method. Bootstrap values (>60%) and amino acid substitutions are mapped to key branches. Intra-and inter-clade reassortants are indicated as boxes.
Yamagata Clade 3 (Yam-3) (blue), Yamagata Clade 2 (Yam-2) (orange) and Victoria Clade 1 (Vic-1) (green) are indicated. Scale bar represents a genetic
distance of 0.008 substitutions/site. Phylogenetic tree for HA gene with complete taxa identity is shown in S1 Fig.
doi:10.1371/journal.pone.0136254.g002
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and Vic-1 from February 2012 to May 2014 in this study were 38.7% (65/168), 28.6% (48/168)
and 32.7% (55/168), respectively. The prevalence of B/Phuket/3073/2013-like intra-clade reas-
sortants was 17.3% (29/168). Considering the number of influenza B virus detected over time
(including those viruses isolated from IMR), a lineage shift (change) from Victoria to Yamagata
Fig 3. Phylogenetic analysis of the NA gene of influenza B viruses in Malaysia from 2012 to 2014.NA sequences of Malaysian influenza B viruses
were compared with WHO recommended candidate vaccine and reference strains. The phylogeny was reconstructed using maximum likelihood (ML)
method. Bootstrap values (>60%) and amino acid substitutions are mapped to key branches. Intra-and inter-clade reassortants are indicated as boxes.
Yamagata Clade 3 (Yam-3) (blue), Yamagata Clade 2 (Yam-2) (orange) and Victoria Clade 1 (Vic-1) (green) are indicated. Scale bar represents a genetic
distance of 0.008 substitutions/site. Phylogenetic tree for NA gene with complete taxa identity is shown in S2 Fig.
doi:10.1371/journal.pone.0136254.g003
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occurred between 2012 and 2013 (Fig 4A). Although co-circulation of Yamagata lineage and
Victoria lineage was observed, the Victoria lineage predominated briefly first in 2012 followed
by the Yamagata lineage in 2013 that remained dominant since then. However, between 2013
and 2014, we observed a clade shift inside the Yamagata lineage: from Yam-2 to Yam-3 (Fig
4B). Notably, all Yam-3 viruses that predominated in 2014 were B/Phuket/3073/2013-like
intra-clade reassortants from Phuket/3073-like subclade.
Evidences from phylogenetic and prevalence analyses in a Malaysian context suggest that a
single intra-clade reassortment event occurring between Wisconsin/01-like and Stockholm/
12-like subclades may contribute to the recent predomination of Phuket/3073-like subclade.
The HA gene that derived from Stockholm/12-like subclade was last detected on February
2013, but the NA gene derived from this subclade was later seen in all Phuket/3073-like sub-
clade viruses, which had HA gene that derived fromWisconsin/01-like subclade (Fig 4).
Another single intra-clade reassortment event was also detected within Vic-1 where a Malay-
sian virus (B/Malaysia/U1429/2013) had HA gene from Vic-1B (represented by B/Odessa/
Fig 4. Lineage and clade shift of influenza B viruses between 2012 and 2014.Monthly distribution of influenza B viruses by (A) lineage and (B) clade.
doi:10.1371/journal.pone.0136254.g004
Influenza B Viruses in Malaysia
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3886/2010) and NA gene from Vic-1A (represented by B/Brisbane/60/2008) (Figs 2 and 3, S1
and S2 Figs). Furthermore, in Yamagata lineage, we detected an inter-clade reassortant (B/
Malaysia/U2214/2013), possessing HA gene from Yam-2 (represented by B/Massachusetts/02/
2012) and NA gene from Yam-3 (represented by B/Wisconsin/01/2010) (Figs 2 and 3, S1 and
S2 Figs). However, these two reassortant forms were found in single virus strains, suggesting
that they were sporadic reassortant viruses.
Evolutionary Dynamics of Phuket/3073-like Subclade
The emergence time of Phuket/3073-like subclade was investigated, by including all 32 Malay-
sian viruses and 446 global influenza B viruses retrieved from GISAID that were phylogeneti-
cally grouped under this subclade (S3–S6 Figs).
Applying a relaxed molecular clock model in the Bayesian MCMC analysis obtained the
estimates of the evolutionary rates for both HA and NA gene at 2.2 (95% HPD: 1.9–2.6) x 10−3
and 3.0 (2.5–3.4) x 10−3 substitutions/site/year, respectively (Table 2), similar to previously
published data [39, 41]. The time of the most recent common ancestor (tMRCA) for HA and
NA gene of Phuket/3073-like subclade were estimated to be 2013.2 (March 2013) (in year frac-
tion; 95% HPD: 2012.9–2013.4, November 2012-May 2013) and 2013.1 (February 2013) (95%
HPD: 2012.8–2013.4, October 2012-May 2013) respectively (Table 2). These estimates collec-
tively suggested that the intra-clade reassortment event could have occurred in March 2013 or
earlier, which is about 10 months before the B/Phuket/3073/2013 vaccine strain was first iso-
lated in Thailand. The maximum clade credibility (MCC) tree reconstruction for HA (Fig 5A)
and NA (Fig 5B) gene of Phuket/3073-like subclade showed that B/Malaysia/U2462/2013 virus
consistently occupied the basal position of this subclade while other Malaysian viruses inter-
mingled with global viruses. This suggested that Malaysia could possibly be the place where
early Phuket/3073 subclade-like viruses have been circulating, from which the virus was dis-
seminated to other places, and that re-introduction back to Malaysia have also occurred.
Influenza B HA and NA Protein Sequence Analysis
In general, all Malaysian Vic-1, Yam-2 and Yam-3 viruses shared more than 99.0% average
nucleotide and amino acid similarity with representative candidate vaccine strains B/Brisbane/
60/2008, B/Massachusetts/02/2012 and B/Wisconsin/01/2010, for both HA and NA gene (S3
Table). These similarities generally decreased every year, reflecting that the Malaysian viruses
were evolving away from respective candidate vaccine strains (S3 Table).
A total of 99 amino acid substitutions on the HA protein were detected in all three clades
when compared to respective representative candidate vaccine strains (S4–S6 Tables). Among
these substitutions, only 15 substitutions occurred on positively selected sites of the four major
epitopes of HA1 subunit and their surrounding regions as reported previously [46–49]
Table 2. Evolutionary rate and age of influenza B Phuket/3073-like subclade.
Gene Rates of evolution(95%
HPD)
tMRCA (95% HPD)(Year
Fraction)
tMRCA (95% HPD)(Month & Year)
HA 2.2 (1.9–2.6) x10-3 2013.2 (2012.9–2013.4) March 2013 (November 2012 –May
2013)
NA 3.0 (2.5–3.4) x10-3 2013.1 (2012.8–2013.4) February 2013 (October 2012 –May
2013)
tMRCA: time of the most recent common ancestor; HPD: highest posterior density
doi:10.1371/journal.pone.0136254.t002
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(Table 3). In particular, N116K substitution (shared by 64 Yam-3 viruses) and H122Y substitu-
tion (shared by 22 Vic-1 viruses) were found in the 120-loop of HA1 subunit. I146V substitu-
tion was shared by 67 Vic-1 viruses in the 150-loop. These substitutions occurred on regions
that serve as antibody binding sites, and could contribute to the structural alteration of the HA
protein, leading to changes in antigenicity [15, 48, 50]. Notably, D194N (D194N based on B/
HongKong/73 numbering; D197N based on B/Brisbane/60/2008 vaccine strain numbering;
D196N based on B/Massachusetts/02/2012 and B/Wisconsin/01/2010 vaccine strain number-
ing) substitution was found on the 190-helix hot spot (HA1 194–196, based on B/HongKong/
73 numbering) which is a potential glycosylation site [47]. This substitution (N-glycosylation)
was detected in all Malaysian viruses, and was also found in the recent Thailand [18] and Bei-
jing [15] strains. Substitution at this amino acid position has been known to alter the
Fig 5. Maximum clade credibility (MCC) tree reconstruction of Phuket/3073-like subclade. (A) HA gene
and (B) NA gene. The 95% highest posterior density (HPD) for the ancestral node is indicated. Timescale is
shown at the bottom of the tree. MCC tree with complete taxa identity is shown in S5 and S6 Figs.
doi:10.1371/journal.pone.0136254.g005
Influenza B Viruses in Malaysia
PLOS ONE | DOI:10.1371/journal.pone.0136254 August 27, 2015 11 / 21
antigenicity of the virus [51] and may help to shield the 190-helix epitope from antibody recog-
nition [47], though the role of D194N substitution in increasing viral fitness requires additional
investigation.
On the NA protein, a total of 127 amino acid substitutions were found in all 3 clades when
compared to respective representative candidate vaccine strains (S7–S9 Tables). Only 2/68
(2.94%) Malaysian viruses from Vic-1 displayed H274Y substitution in the NA active sites,
which was a neuraminidase inhibitor (oseltamivir)-resistant substitution [52]. No other substi-
tutions were observed on the NA active sites that confer to neuraminidase inhibitor resistance,
as reported elsewhere [53–57], suggesting that the virus would still be sensitive to neuramini-
dase inhibitors. Notably, three Malaysian viruses from Vic-1 and all viruses from Yam-3
including the Phuket/3073-like subclade had a novel D463N substitution on a non-active site,
which introduced a potential glycosylation at that position, potentially shielding the nearby
active site. Further functional study of this substitution is warranted.
Comparison of protein sequences with candidate vaccine strains (B/Brisbane/60/2008 for
Vic-1, B/Massachusetts/02/2012 for Yam-2 and B/Wisconsin/01/2010 for Yam-3) allowed us
to identify several signature amino acid substitutions shared by major clades and subclades.
Interestingly, 21 out of 32 Malaysian viruses within Phuket/3073-like subclade had an addi-
tional L172Q substitution apart from sharing N116K, K298E and E312K substitutions on the
HA protein with Wisconsin/01-like subclade (Table 4). However, in the NA protein, all viruses
within Phuket/3073-like subclade had additional I45V, E320K and E340D substitutions besides
sharing L73P and K343E substitutions on the NA protein with Stockholm/12-like subclade.
Table 3. Amino acid substitutions found on the HA protein of influenza B viruses.
Subunit Epitope (Residue location) Vic-1 (n = 67) Yam-2 (n = 53) Yam-3 (n = 71)
HA1 120-loop (116–137) H122Y (22) N116K (64)
T121A (10)
V124A (2)
150-loop (141–150) I146V (67)
160-loop (162–167) A169E (2)
190-helix (194–202) D197N (66) D196N (53) D196N (71)
T199N (2) S202N (6)
A202E (21)
Surrounding region V6A (2) V6I (18) V11A (2)
G68S (2) T75N (2) V29A (7)
V90I (6) V176I (2) L172Q (30)
A154E (8) Y178N (3) S207P (3)
N171S (4) G229D (3) M251V (13)
V177I (5) T234R (3) K298E (64)
I180V (3) E312K (64)
V190I (3)
K209N (18)
I267V (2)
HA2 N46D (6)
Only amino acid substitutions shared by 2 viruses or more are reported in this table. Substitutions are compared with vaccine strains of respective clades
(S4–S6 Tables). Amino acid substitutions are numbered according to respective vaccine strains (B/Brisbane/60/2008 for Vic-1, B/Massachusetts/02/2012
for Yam-2, B/Wisconsin/01/2010 for Yam-3). Bold and italic text indicate previously reported positively selected sites. The number of Malaysian inﬂuenza
viruses having the substitution is indicated inside parenthesis.
doi:10.1371/journal.pone.0136254.t003
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These molecular signatures further corroborate the phylogenetic tree that the HA and NA pro-
tein of Phuket/3073-like subclade was originated from the Wisconsin/01-like and Stockholm/
12-like subclades, respectively.
Besides, within Vic-1 lineage, additional H122Y and A202E substitutions were detected on
the HA protein and A389T substitution on the NA protein. These substitutions were shared by
22 viruses within Vic-1A (characterized by I146V substitution on HA protein), which were
grouped under V1A-1 subclade (Figs 2 and 3, S1 and S2 Figs). The remaining strains within
Vic-1A did not acquire H122Y and A202E substitutions on the HA protein but share addi-
tional S295R and E358K substitutions on the NA protein. They were grouped under V1A-2
subclade (Figs 2 and 3, S1 and S2 Figs).
Comparison of Demographic and Clinical Characteristics between
Influenza Lineages
A comparison of demographic and clinical characteristics between Yamagata and Victoria line-
age-infected patients is shown in Table 5. Patients infected by the Yamagata lineage viruses
were significantly older than patients infected by the Victoria lineage virus, with mean age
(years±S.D) for Yamagata being 43.58±18.22 versus Victoria being 32.11±16.18 (p<0.001;
Independent Samples t-Test). Similarly, a higher proportion of adults over 56 years old were
infected by the Yamagata lineage than the Victoria lineage (51.8% versus 14.3%; p = 0.006;
Pearson’s chi-square test). In contrast, we found no significant difference in day(s) onset of
Table 4. Major signature amino acid substitutions. These substitutions are summarized from S4–S9 Tables.
Vic-1 Yam-3
Vic-1A
Protein V1A-1 V1A-2 Vic-1B Yam-2 Stockholm/12-like Wisconsin/01-like Phuket/3073-like
HA N75K R48K S150I
N165K P108A N165Y
S172P T181A D196N
I146V L58P D196N G229D
H122Y V29A N116K
A202E L172Q K298E
M251V E312K
L172Q
NA I204V I148V Q42R
A358E T106I A68T
D329N S295R T125K
N340D K186R
A389T D463N
S295R A465T
E358K D340N N340D
L73P L73P
K343E K343E
I45V
E320K
Amino acid substitutions are numbered according to vaccine strains (B/Brisbane/60/2008 for Vic-1, B/Massachusetts/02/2012 for Yam-2, B/Wisconsin/01/
2010 for Yam-3). Bold and italic text indicates substitutions shared by two subclades or more.
doi:10.1371/journal.pone.0136254.t004
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symptoms (number of days after the first appearance of symptoms) between the two different
lineages. Besides, only two symptoms: nasal congestion and sore throat were found to have an
association with patients infected by Victoria lineage viruses (p = 0.033, OR = 2.22 and
p = 0.020, OR = 2.49 respectively; Pearson’s chi-square test).
In addition, when binary logistic regression was used to predict the likelihood of patients
infected with either Yamagata or Victoria lineage virus, four factors made a unique statistically
significant contribution (p<0.05) to the regression model: patients56 years old, nasal con-
gestion, headache and sore throat. The strongest predictors of a Yamagata lineage-infection
were headache and age56 years old (aOR: 3.603, 95% CI: 1.316–9.896, p: 0.013 and aOR:
4.33, 95% CI: 1.184–15.838, p: 0.027, respectively), while the strongest predictors of a Victoria
lineage-infection were nasal congestion and sore throat (aOR: 2.833 (1/0.353) 95% CI: 1.038–
Table 5. Comparison on the demographic and clinical characteristics of patients infected by influenza B Victoria and Yamagata lineages.
Victoria Lineage Yamagata Lineage Yamagata vs Victoria (ref.)
Characteristics (n = 56) (n = 114) p OR (95% CI) B SE p aOR 95% CI
Demographic Features
Mean (± S.D.) age in years 32.11 ± 16.18 43.58 ± 18.22 <0.001a - - - - - -
No. (%) of patients 24 yrs
old
21 (37.5) 20 (17.5) 0.006b - ref. 0.085c ref.
No. (%) of patients25-55
yrs old
27 (48.2) 35 (30.7) - 0.576 0.459 0.210c 1.779 0.723–4.377
No. (%) of patients 56
years old
8 (14.3) 59 (51.8) - 1.466 0.662 0.027c 4.33 1.184–15.838
Clinical Features
Median (IQR) days onset
of symptoms
4 (2–6) 4 (3–5) 0.670a - -0.032 0.089 0.722c 0.969 0.814–1.153
No. (%) of patients with:
Sneezing Yes 44 (78.6) 81 (71.1) 0.296b 1.49 (0.70–3.18) -0.497 0.522 0.341c 0.608 0.219–1.692
No 12 (21.4) 33 (28.9) ref. ref.
Nasal Discharge Yes 43 (76.8) 88 (77.2) 0.953b 0.98 (0.46–2.09) 0.565 0.523 0.280c 1.76 0.631–4.910
No 13 (23.2) 26 (22.8) ref. ref.
Nasal Congestion Yes 44 (78.6) 71 (62.3) 0.033b 2.22 (1.06–4.67) -1.042 0.513 0.042c 0.353 0.139–0.963
No 12 (21.4) 43 (37.7) ref. ref.
Headache Yes 40 (71.4) 89 (78.1) 0.341b 0.70 (0.34–1.46) 1.282 0.514 0.013c 3.603 1.316–9.896
No 16 (28.6) 25 (21.9) ref. ref.
Sore throat Yes 46 (82.1) 74 (64.9) 0.02b 2.49 (1.14–5.45) -1.42 0.542 0.009c 0.242 0.084–0.699
No 10 (17.9) 40 (35.1) ref. ref.
Hoarseness of voice Yes 43 (76.8) 93 (81.6) 0.463b 0.75 (0.34–1.63) 0.874 0.523 0.095c 2.398 0.860–6.683
No 13 (23.2) 21 (18.4) ref. ref.
Muscle ache Yes 45 (80.4) 97 (85.1) 0.434b 0.72 (0.31–1.66) -0.467 0.583 0.423c 0.627 0.200–1.964
No 11 (19.6) 17 (14.9) ref. ref.
Cough Yes 54 (96.4) 109 (95.6) 0.802b 1.24 (0.23–6.60) -0.681 1.059 0.520c 0.506 0.064–4.032
No 2 (3.6) 5 (4.4) ref. ref.
n: number of patients; OR: odds ratio; CI: conﬁdence interval; B: coefﬁcient; SE: standard error; SD: standard deviation; aOR: adjusted odds ratio; ref:
reference group; p: level of signiﬁcance (2-tailed) at the 0.05 level
ap-value calculated by Independent Samples t-Test
bp-value calculated by Pearson’s Chi-square test/Fischer’s Exact test
cp-value calculated by Binary Logistic Regression
doi:10.1371/journal.pone.0136254.t005
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7.194 (1/0.139–1/0.963), p:0.042 and aOR: 4.132 (1/0.242), 95% CI: 1.431–11.905 (1/0.084–1/
0.699), p: 0.009, respectively) (Table 5).
Discussion
Environmental factors such as higher amount of rainfall, higher relative humidity and colder
temperature were found to increase the risk of seasonal influenza transmission [58, 59]. These
factors may affect virus survivability by lengthening the protective effect of droplets on viruses
trapped on fomites or aerosols [26, 58–60]. In particular, colder temperature has been found
promoting influenza virus survival in aerosols [25], whereas higher humidity might increase
the amount of virus particles that is deposited on the surface, hence encouraging contact trans-
mission of the virus [57]. Malaysia has a tropical equatorial climate accompanied by two mon-
soon seasons, the Southwest Monsoon (May to September) and Northeast Monsoon
(November to March). The Northeast Monsoon brings in more rainfall compared to the
Southwest Monsoon [61]. In this study, as expected, we observed that the peak of the total
amount of rainfall, number of rain days and relative humidity coincided with the Malaysian
Northeast Monsoon season (Fig 1). The lowest ground temperature was also recorded during
this period. Based on bivariate correlation, higher number of influenza cases was found to asso-
ciate significantly with lower temperature and higher amount of rainfall, rain days and relative
humidity (Table 1). Similar association for influenza A was reported in previous studies as well
[26, 28]. However, when partial correlation and multiple linear regression was performed, only
ground temperature shows significant negative association with no. of influenza cases and was
the strongest predictor among all meteorological factors (Table 1). The actual causal relation-
ship between ground temperature and influenza seasonality remains in question. Though,
these findings suggest that the influenza A and B seasonal activity probably coincided with a
combination of colder and rainier Malaysian Northeast Monsoon instead of the Southwest
Monsoon. A significant negative correlation between particulate matter (PM10) and influenza
activity was also found in this study (Table 1). Similar relationship was reported in Southern
China [62, 63], which postulated that lower PM10 would result in higher ultraviolet radiation
(UVR) that may decrease immune function. However, the role of UVR in increasing host sus-
ceptibility to influenza remains controversial and requires further investigation.
There was a difference in the overall prevalence between influenza A and B viruses during
the study period. The number of influenza B cases was consistently lower compared to influ-
enza A cases every year, and there is a time lag between their peak activities (Fig 1C). On the
basis of several reports indicating lower rates of nucleotide mutation and selection pressure in
influenza B viruses compared to influenza A viruses [39, 64], it is tempting to suggest that they
may play a role in the lower prevalence of influenza B viruses. Though such description
remains speculative as prevalence studies could be affected by sampling artifacts or the scale of
surveillance. While both influenza and B viruses continue to co-circulate, we also observed a
slight increase of influenza B incidence when influenza A incidence decreased) (Fig 1C) The
increase of influenza B incidence also coincided with shifts in the predominant influenza B
lineage (from Victoria lineage in 2012 to Yamagata lineage in 2013) and clade (from Yam-2 in
2013 to Yam-3 in 2014) (Fig 4). The mechanism on how the decrease of influenza A incidence
may lead to a change of influenza B lineage and clade requires further investigation.
However, we hypothesize that the turnover of antigenically distinct lineages from Victoria
lineage in 2012 to Yamagata lineage in 2013 could be a result of immune selection due to accu-
mulated herd immunity in the human population [39]. We suggest that the less dominant Yama-
gata lineage with distinct antigenicity may regain dominance when the predominating Victoria
lineage has induced sufficient herd immunity in the hosts, either through recovery from infection
Influenza B Viruses in Malaysia
PLOS ONE | DOI:10.1371/journal.pone.0136254 August 27, 2015 15 / 21
or vaccination. It was expected that such alteration of dominance would continue and hence Vic-
toria lineage would become dominant again in 2014. Surprisingly, the Yamagata lineage contin-
ued its domination in the influenza B viral population with a clade shift from Yam-2 in 2013 to
Yam-3 in 2014 that consists mainly of B/Phuket/3073/2013-like viruses (Fig 4).
Besides possessing an intra-clade reassortment property (HA fromWisconsin/01-like sub-
clade and NA from Stockholm/12-like subclade) (Figs 2 and 3), Phuket/3073-like subclade
viruses also shared several signature amino acid substitutions (Table 4). Haemagglutination
inhibition (HI) tests by WHO have shown that the representative B/Phuket/3073/2013 strains
have acquired significant antigenic drift (4 folds of titer reduction) from the B/Wisconsin/1/
2010 strains and (2 folds of titer reduction) from the B/Stockholm/12/2011 strains, in which
both are representatives of B/Phuket/3073/2013 HA and NA parental clades, respectively [65].
Whether the signature amino acid substitutions may play a role in antigenic drift will require
further in-depth molecular experiments to confirm, as antigenic characterization was not per-
formed such that the detection of antigenic drift relied on prediction based on protein
sequences. Though, overall, it is worth highlighting that a combination of meteorological fac-
tors, influenza population prevalence, genetic reassortment and antigenic drift and possibly
other factors (vaccination uptake by the susceptible young or elderly population, socio-eco-
nomic factors etc.) may shape the epidemiological and evolutionary dynamics of influenza B
viruses in the lineage, clade and subclade levels.
Our analysis on the evolutionary dynamics of Phuket/3073-like subclade provides further
evidence that Southeast Asia region with tropical and subtropical climate might be a regional
and global hub for the emergence of novel influenza viruses [20, 22]. Notably, there is almost a
two-year difference between the estimated time of intra-clade reassortment event (February-
March 2013) (Table 2) and time when B/Phuket/3073/2013 vaccine strain was announced on
September 2014 for the Southern Hemisphere and on February 2015 for the Northern Hemi-
sphere [23]. This suggests that influenza B surveillance in Malaysia and other Southeast Asian
countries should be intensified for early detection of emerging strains with epidemic potential.
Our observation of notable age difference between influenza B lineages, with Yamagata
viruses were more likely to infect the older adults (56 years old) in the population, has also
been observed in previous studies (Table 5) [14, 42]. This could be the result of a difference in
background population immunity, in which older adults with weaker immunity are more sus-
ceptible to the current Yamagata strains due to their recent evolution. However, lineage-spe-
cific transmissibility among older adults is still currently unclear. We also observed that
Yamagata-infected older patients were more likely to experience headache while Victoria-
infected patients were more likely to experience nasal congestion and sore throat. Since this is
the first association found between these symptoms with specific lineages, it would require
additional data and studies to provide a more conclusive evidence of this association.
In summary, this study highlights the importance of continuous surveillance of influenza B
viruses in order to better understand the current epidemiology and evolutionary dynamics of
these viruses in Malaysia. The main limitation of this study is that only HA and NA surface
genes were sequenced and analyzed, which were unable to detect the reassortment involving
other internal genes. Phylogenetic analysis of all gene segments will provide a better under-
standing on influenza B evolution.
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